P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression

Recently, a novel class of transcripts, long non-coding RNAs (lncRNAs), is being identified at a rapid pace. These RNAs have critical roles in diverse biological processes, including tumorigenesis. Here we report that taurine-upregulated gene 1 (TUG1), a 7.1-kb lncRNA, recruiting and binding to polycomb repressive complex 2 (PRC2), is generally downregulated in non-small cell lung carcinoma (NSCLC) tissues. In a cohort of 192 NSCLC patients, the lower expression of TUG1 was associated with a higher TNM stage and tumor size, as well as poorer overall survival (P<0.001). Univariate and multivariate analyses revealed that TUG1 expression serves as an independent predictor for overall survival (P<0.001). Further experiments revealed that TUG1 expression was induced by p53, and luciferase and chromatin immunoprecipitation (ChIP) assays confirmed that TUG1 was a direct transcriptional target of p53. TUG1 knockdown significantly promoted the proliferation in vitro and in vivo. Moreover, the lncRNA-mediated regulation of the expression of HOX genes in tumorigenesis and development has been recently receiving increased attention. Interestingly, inhibition of TUG1 could upregulate homeobox B7 (HOXB7) expression; ChIP assays demonstrated that the promoter of HOXB7 locus was bound by EZH2 (enhancer of zeste homolog 2), a key component of PRC2, and was H3K27 trimethylated. This TUG1-mediated growth regulation is in part due to specific modulation of HOXB7, thus participating in AKT and MAPK pathways. Together, these results suggest that p53-regulated TUG1 is a growth regulator, which acts in part through control of HOXB7. The p53/TUG1/PRC2/HOXB7 interaction might serve as targets for NSCLC diagnosis and therapy.

[1]  Xinyan Wu,et al.  HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. , 2006, Cancer research.

[2]  J. Rinn,et al.  linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis. , 2013, Genes & development.

[3]  Shuhan Sun,et al.  Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence‐free survival after hepatectomy , 2012, Hepatology.

[4]  D. S. Gross,et al.  Chromatin , 2020, Definitions.

[5]  Howard Y. Chang,et al.  Extensive and coordinated transcription of noncoding RNAs within cell cycle promoters , 2011, Nature Genetics.

[6]  Libing Song,et al.  Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival , 2009, Cancer.

[7]  Pieter C. Dorrestein,et al.  ncRNA- and Pc2 Methylation-Dependent Gene Relocation between Nuclear Structures Mediates Gene Activation Programs , 2011, Cell.

[8]  Atif Shahab,et al.  Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. , 2007, Cell stem cell.

[9]  Paulo P. Amaral,et al.  Noncoding RNA in development , 2008, Mammalian Genome.

[10]  J. Rinn,et al.  A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.

[11]  Howard Y. Chang,et al.  A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression , 2011, Nature.

[12]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[13]  P. Fraser,et al.  No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.

[14]  J. Rinn,et al.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.

[15]  Paulo P. Amaral,et al.  Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. , 2008, Genome research.

[16]  Zhiming Cai,et al.  Long intergenic non‐coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder , 2013, Journal of surgical oncology.

[17]  C. Ishioka,et al.  Locus-specific mutation databases: pitfalls and good practice based on the p53 experience , 2006, Nature Reviews Cancer.

[18]  N. Rao,et al.  HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma , 2013, Cancer.

[19]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[20]  Yi Qu,et al.  Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis , 2009, PloS one.

[21]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[22]  D. Ribatti,et al.  HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients , 2011, Leukemia.

[23]  S. Boyle,et al.  Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus , 2012, Proceedings of the National Academy of Sciences.

[24]  M. Esteller,et al.  Intronic RNAs mediate EZH2 regulation of epigenetic targets , 2012, Nature Structural &Molecular Biology.

[25]  J. Minna,et al.  Focus on lung cancer. , 2002, Cancer cell.

[26]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[27]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[28]  C. Cepko,et al.  The Noncoding RNA Taurine Upregulated Gene 1 Is Required for Differentiation of the Murine Retina , 2005, Current Biology.

[29]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  J. Mattick,et al.  The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. , 2011, Cancer research.

[31]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[32]  Yusuke Nakamura,et al.  Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction , 2006, Journal of Human Genetics.

[33]  Joseph C. Pearson,et al.  Modulating Hox gene functions during animal body patterning , 2005, Nature Reviews Genetics.

[34]  L. Ohno-Machado,et al.  Genomic Analysis of Mouse Retinal Development , 2004, PLoS biology.

[35]  Bangshun He,et al.  Analysis of long non-coding RNA expression profiles in gastric cancer. , 2013, World journal of gastroenterology.

[36]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[37]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[38]  John T. Wei,et al.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression , 2011, Nature Biotechnology.

[39]  Shiyong Wu,et al.  Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma , 2014, Molecular carcinogenesis.

[40]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[41]  X. Bian,et al.  HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression , 2011, Clinical Cancer Research.

[42]  M. Rijnkels,et al.  A noncoding RNA is a potential marker of cell fate during mammary gland development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Qiang Zhang,et al.  Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[44]  Paulo P. Amaral,et al.  The Eukaryotic Genome as an RNA Machine , 2008, Science.

[45]  Xiao-Jun Ma,et al.  The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway , 2011, Proceedings of the National Academy of Sciences.

[46]  Saraswati Sukumar,et al.  The Hox genes and their roles in oncogenesis , 2010, Nature Reviews Cancer.